期刊文献+

肺炎链球菌荚膜多糖特异性IgG抗体定量ELISA检测及质量控制要求 被引量:6

ELISA for quantitation of human antibodies to pneumococcal polysaccharides and requirements in quality control of determination
下载PDF
导出
摘要 检测肺炎链球菌荚膜多糖(PPS)特异性抗体的酶联免疫吸附试验多年来经历了两次主要改进。介绍了WHO推荐的人血清抗肺炎链球菌(Streptococcus pneumoniae)荚膜多糖抗体IgG定量ELISA(Pn PS ELISA)检测方法、关键试剂、局限性以及方法验证等内容。ELISA定量检测法,为预防肺炎链球菌的婴幼儿侵袭性疾病提供准确的抗体水平,并对肺炎链球菌疫苗的临床评价提供血清学证据。人血清中肺炎链球菌荚膜多糖抗体IgG是判断肺炎链球菌疫苗效力的重要指标。 Over the years, the specific ELISA for detection antibody to capsular polysaccharide ( PPS ) of Streptococcus pneumoniae has experienced two major improvements. The paper introduces the WHO recommended quantitative ELISA ( Pn PS ELISA) in determination of human serum IgG antibody to pneumococcal capsular polysaccharide with the key reagents, limitations in its application, and its verification, etc. If the value of IgG antibody level in sera determinated by Pn PS ELISA is above protective threshold, the sera can prevent of invasive disease in infants. The protective threshold provides serological data in the registration and serves as the primary endpoint of the protective efficacy for pneumococcal vaccine.
出处 《微生物学免疫学进展》 2014年第4期61-67,共7页 Progress In Microbiology and Immunology
基金 国家科技支撑计划(2008BAI66B01)
关键词 肺炎链球菌 抗荚膜多糖IgG抗体含量 酶联免疫吸附试验 检测质量控制要求 Streptococus pneumonia Anticapsular polysaccharide IgG level ELISA Requirements in quality control of determination
  • 相关文献

参考文献32

  • 1杨耀,栗克喜,宋绍忠,张云,江山,谢全海,兰芳,黄剑,黎云东,李凤祥,袁曾麟,郭淑英,石继春,何莉.23价肺炎球菌多糖疫苗临床试验[J].预防医学情报杂志,2007,23(4):390-391. 被引量:34
  • 2World HealthOrganization.Expert committee on biological standardization.Recommendations to assure the quality,safety and efficacy of pneumococcal conjugate vaccines[R].Geneva:WHO Technical Report Series,2009,No 927,Annex 2.
  • 3Schiffman G,Douglas RM,Bonner MJ,et al.A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines.I.Mathod for the radioimmunoassay of anticapsular antibodies and comparison with other techniques[J].J Immunol Methods,1980,33(2):133-144.
  • 4Musher D M,Watson DW,Baughn RE.Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infections?[J].J Infect Dis,1990,161(4):736-740.
  • 5Nielsen SV,Sorensen UB,Henrichsen J.Antibodies against pneumococcal C-polysaccharide are not protective[J].Microb Pathog,1993,14(4):299-305.
  • 6Siber GR,Priehs C,Madore DV.Standardization of antibody assays for measuring the response to pneumococcal infection and immunization[J].Pediatr Infect Dis,1989,8(Suppl):S84-S91.
  • 7Gestur V,Ingileif J,Steinn J,et al.Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae[J].J Infect Dis,1994,170(3):592-599.
  • 8Concepcion NF,Frasch CE..Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay[J].Clin Diagn Lab Immunol,2001,8(2):266-272.
  • 9Yu X,Sun Y,Frasch C.,Pneumococcal capsular polysaccharide preparations may contain non-c-polysaccharide contaminants that are immunogenic[J].Clin Diagn Lab Immunol,1999,6(4):519-524.
  • 10Ron D,Juhani E,Claudo L,et al.Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants[J].Infect Immun,1998,66(5):2093-2098.

二级参考文献3

  • 1Butler J C,Breiman R F,Campbell J F,et al.Pneumococcal polysaccharide vaccine efficacy[J].JAMA,1993,270:1826-1831.
  • 2Chu C,Schneerson R,Robbins J B,et al.Further studies on the immunogenicity of H.influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates[J].Infect Immun,1983,39:233.
  • 3袁曾麟.肺炎球菌感染及其疫苗预防[J].中国计划免疫,1997,3(2):90-93. 被引量:11

共引文献33

同被引文献59

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部